Quest Diagnostics’ Acquisition of Haystack Oncology

Goodwin advised Haystack Oncology on the deal.Haystack Oncology announced its definitive agreement to be acquired by Quest Diagnostics (NYSE: DGX). Under the terms of the agreement, Quest…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now